XML 23 R13.htm IDEA: XBRL DOCUMENT v3.25.0.1
Segment Data
 3 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Segment Data Segment Data
The Company's organizational structure is based upon three worldwide business segments: BD Medical (“Medical”), BD Life Sciences (“Life Sciences”) and BD Interventional (“Interventional”). The Company's segments are strategic businesses that are managed separately because each one develops, manufactures and markets distinct products and services. Segment disclosures are on a performance basis consistent with internal management reporting. The Company evaluates performance of its business segments and allocates resources to them primarily based upon segment operating income, which represents revenues reduced by product costs and operating expenses.
Revenues by segment, organizational unit and geographical areas for the three-month periods are detailed below. The Company has no material intersegment revenues.
Three Months Ended December 31,
(Millions of dollars)20242023
United StatesInternationalTotalUnited StatesInternationalTotal
Medical
Medication Delivery Solutions$694 $430 $1,124 $639 $413 $1,052 
Medication Management Solutions659 142 801 594 153 747 
Pharmaceutical Systems104 314 418 127 304 431 
Advanced Patient Monitoring159 113 271 — — — 
Total segment revenues$1,615 $999 $2,615 $1,360 $870 $2,230 
Life Sciences
Specimen Management (a)$238 $223 $462 $234 $213 $447 
Diagnostic Solutions (a)212 262 474 210 256 467 
Biosciences153 208 361 143 232 375 
Total segment revenues$603 $694 $1,297 $587 $701 $1,288 
Interventional
Surgery$303 $92 $395 $280 $88 $369 
Peripheral Intervention253 220 473 234 220 454 
Urology and Critical Care306 83 389 287 78 365 
Total segment revenues$861 $396 $1,257 $802 $386 $1,188 
Total Company revenues$3,080 $2,089 $5,168 $2,749 $1,957 $4,706 
(a)    During the first quarter of fiscal year 2025, Life Sciences split its former Integrated Diagnostic Solutions organizational unit into two units to better align BD resources with the distinct needs of each business.
Segment income for the three-month periods was as follows:
 Three Months Ended
December 31,
(Millions of dollars)20242023
Income Before Income Taxes
Medical$492 $535 
Life Sciences383 372 
Interventional387 291 
Total Segment Operating Income1,263 1,198 
Integration, restructuring and transaction expense(92)(75)
Net interest expense (132)(77)
Other unallocated items (a)(733)(688)
Total Income Before Income Taxes$306 $359 
(a)Primarily comprised of foreign exchange, certain general and administrative expenses and share-based compensation expense.